CREATINE KINASE (CK) - ANVISA Registration 80022230299
Access comprehensive regulatory information for CREATINE KINASE (CK) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80022230299 and manufactured by GOLD ANALISA DIAGNOSTICA LTDA. The registration is held by GOLD ANALISA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including KATAL BIOTECNOLOGICA INDรSTRIA E COMรRCIO LTDA, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80022230299
25351111641202504
03142794000116
Company Information
Dates and Status
Aug 18, 2025
VIGENTE
09/18/2025 19:00:01
CREATINOQUINASE (CK)
FAMรLIA CK TOTAL
KATAL BIOTECNOLOGICA INDรSTRIA E COMรRCIO LTDA
10377390318
Jun 02, 2025
CREATINOQUINASE (CK)
CK NAC Automaรงรฃo - Linha DT
DAILYTECH LATINO AMERICA LTDA
80657030079
Apr 07, 2025
CREATINOQUINASE (CK)
CK-NAC
IN VITRO DIAGNOSTICA LTDA
10303460560
Mar 17, 2025
CREATINOQUINASE (CK)
CK (W) Simplex
TASCOM CO., LTD
80074330020
Feb 17, 2025
CREATINOQUINASE (CK)
CK Simplex
TASCOM CO., LTD
80074330007
Jan 06, 2025

